ClinicalTrials.gov
public full text
Public Domain
SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Soluble ST2 and Cardiovascular Outcome#836963
- Safety and efficacy of sglt2 inhibitors: A multiple-treatment meta-analysis of clinical decision indicators#935601
- SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications.#1167005
- The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function#851602
- Data Sheet 1_Disproportionate reporting of euglycaemic and diabetic ketoacidosis with SGLT-2 inhibitors across expanding cardiorenal indications: a cross-database study of FAERS and JADER.docx#635006
Record · ID 467532
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive